日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Author Correction: Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial

作者更正：多替拉韦可恢复晚期 HIV-1 患者的肠道菌群，而达芦那韦则不能：一项开放标签、随机临床试验

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-026-72458-w
Català-Moll, Francesc; Blázquez-Bondia, Carlos; Farré-Badia, Judit; Torres, Ferran; Manzardo, Christian; Bonfill, Eva; Curran, Adrià; Domingo, Pere; Podzamczer, Daniel; Force, Lluís; Falcó, Vicenç; Parera, Mariona; Casadellà, Maria; Miró, José Maria; Noguera-Julian, Marc; Paredes, Roger
肠道菌群
HIV
微生物学
发表日期：2026
文献求助 收藏

ColoStem, a core oncofetal signature that identifies poor prognosis colorectal tumors

ColoStem是一种核心的癌胚特征，可识别预后不良的结直肠肿瘤。

期刊:British Journal of Cancer
影响因子:6.8
doi:10.1038/s41416-025-03280-2
Solé, Laura; Canton, Eric; Maqueda, María; Lobo-Jarne, Teresa; Barbáchano, Antonio; Torres, Ferran; Cabré-Romans, Julia-Jié; Montoto, Ángela; Fernández-Ibarrondo, Lierni; Martínez-Garcia, Daniel; Guix, Marta; Larrubia-Loring, Mónica; Montagut, Clara; Muñoz, Alberto; Bigas, Anna; Iglesias, Mar; Bellosillo, Beatriz; Espinosa, Lluís
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Clinical Trial: Early Nivolumab Addition to Regorafenib in Patients With Hepatocellular Carcinoma in Second-Line (The GOING Trial)

临床试验：在二线治疗中，早期在瑞戈非尼治疗肝细胞癌患者中加用纳武利尤单抗（GOING试验）

期刊:Alimentary Pharmacology & Therapeutics
影响因子:6.7
doi:10.1111/apt.70578
Sanduzzi-Zamparelli, Marco; Matilla, Ana; Lledo, José Luis; Muñoz-Martínez, Sergio; Varela, María; Iñarrairaegui, Mercedes; Perelló, Christie; Mínguez, Beatriz; Llarch, Neus; Márquez, Laura; Guerrero, Antonio; Iserte, Gemma; Castaño-García, Andrés; Carrión, Laura; Fortuny, Marta; Rimola, Jordi; García-Criado, Ángeles; Domenech, Gema; Torres, Ferran; Rios-Guillermo, José; Boix, Loreto; Samper, Esther; Kateb, Àngels; Bruix, Jordi; Reig, Maria
细胞生物学
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Dolutegravir restores gut microbiota in late-stage HIV-1 unlike darunavir: an open-label, randomized clinical trial

多替拉韦可恢复晚期 HIV-1 患者的肠道菌群，而达芦那韦则无此作用：一项开放标签、随机临床试验

期刊:Nature Communications
影响因子:
doi:10.1038/s41467-026-69846-7
Català-Moll, Francesc; Blázquez-Bondia, Carlos; Farré-Badia, Judit; Torres, Ferran; Manzardo, Christian; Bonfill, Eva; Curran, Adrià; Domingo, Pere; Podzamczer, Daniel; Force, Lluís; Falcó, Vicenç; Parera, Mariona; Casadellà, Maria; Miró, José Maria; Noguera-Julian, Marc; Paredes, Roger
HIV
肠道菌群
微生物学
发表日期：2026
文献求助 收藏

Use of Bayesian approaches in oncology clinical trials: A cross-sectional analysis

贝叶斯方法在肿瘤临床试验中的应用：一项横断面分析

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2025.1548997
Lopez-Rey, Borja G; Carot-Sans, Gerard; Ouchi, Dan; Torres, Ferran; Pontes, Caridad
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO study

癌症门诊患者血栓风险特征分析：观察性、前瞻性、多中心CARTAGO研究结果

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyae334
Trujillo-Santos, Javier; García-Escobar, Ignacio; Salgado, Mercedes; Araújo, António; Martínez-de-Castro, Eva; Molina, Raquel; Castellón-Rubio, Victoria E; Domènech, Pere; Gallardo, Enrique; Colomé, Esteve; Torres, Ferran; Benítez-Montañez, José-Carlos; Porta, Rut; Lobo-de-Mena, Míriam; Malheiro, Mariana; Font, Carme; Brozos-Vázquez, Elena; Garicano, Fernando; Sapena, Víctor; Costa, Ana-Lucia; Albuquerque, Ana-Cristina; Cerezuela, Pablo
肿瘤
心血管
AGO
肿瘤免疫
发表日期：2025
文献求助 收藏

Expression of SREBF2 and HMGCR discriminates the viability of steatotic grafts for human liver transplantation

SREBF2和HMGCR的表达可以区分脂肪肝移植物是否适合用于人类肝移植。

期刊:Journal of Lipid Research
影响因子:4.1
doi:10.1016/j.jlr.2025.100901
Baulies, Anna; Torres, Sandra; Fucho, Raquel; Núñez, Susana; Torres, Ferran; Ferrer-Fàbrega, Joana; Díaz, Alba; Rico, Naira; García-Valdecasas, Juan Carlos; Fuster, Josep; Adalia, Ramon; Paredes, David; Rimola, Antoni; Fernández-Checa, José C; García-Ruiz, Carmen
脂肪肝
GCR
代谢
发表日期：2025
文献求助 收藏

Polymorphic Single-Nucleotide Variants in miRNA Genes and the Susceptibility to Colorectal Cancer: Combined Evaluation by Pairwise and Network Meta-Analysis, Thakkinstian's Algorithm and FPRP Criterium

miRNA基因中的多态性单核苷酸变异与结直肠癌易感性：成对和网络荟萃分析、Thakkinstian算法和FPRP标准的联合评估

期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.70621
Liu, Qing; Archilla, Ivan; Lopez-Prades, Sandra; Torres, Ferran; Camps, Jordi; Cuatrecasas, Miriam
miRNA
肿瘤
肠癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Liver cancer risk and changes in lifestyle habits after successful hepatitis C virus therapy post-DAA HCV therapy: lifestyle changes and liver cancer risk

丙型肝炎病毒DAA治疗成功后，生活方式改变与肝癌风险的关系：生活方式改变与肝癌风险

期刊:BMC Gastroenterology
影响因子:2.6
doi:10.1186/s12876-025-03611-w
Granel, Núria; Iserte, Gemma; Bartres, Concepció; Llarch, Neus; Pla, Anna; Sapena, Víctor; Mariño, Zoe; Lens, Sabela; Vilana, Ramón; Nuñez, Isabel; Darnell, Anna; Belmonte, Ernest; García-Criado, Ángeles; Díaz, Alba; Sanduzzi-Zamparelli, Marco; Fuster, Carla; Muñoz-Martínez, Sergio; Ayuso, Carmen; Rimola, Jordi; Forner, Alejandro; Soler, Alexandre; Torres, Ferran; Ríos, José; Bruix, Jordi; Moon, Andrew M; Forns, Xavier; Reig, María
肿瘤
肿瘤免疫
微生物学
肝癌
肝炎
发表日期：2025
文献求助 收藏

Indolent cancer and pattern of progression: Two missing parameters in trial design for hepatology

惰性癌及其进展模式：肝病学试验设计中缺失的两个参数

期刊:Hepatology
影响因子:15.8
doi:10.1097/HEP.0000000000000527
Iavarone, Massimo; Nault, Jean-Charles; Cabibbo, Giuseppe; Torres, Ferran; Reig, Maria
肿瘤
肿瘤免疫
发表日期：2024
文献求助 收藏